Research Headlines - Light-sensitive molecules for new disease therapies

[Source: Research & Innovation] Peptidomimetics are small molecules that mimic short natural proteins - peptides - and produce the same effects as their natural counterparts. An EU-funded project is developing peptidomimetics that can alternate between biologically active and inactive forms when exposed to light. The technique could lead to new light-controlled drugs which can be turned off and on when needed to treat cancers and other diseases.

from EUROPA - Syndicated Research News Feed https://ift.tt/2UhE2JH
via IFTTT

Comments

Popular posts from this blog

Research Headlines - An inbuilt firefighting system for buses

Research Headlines - Harnessing the sun to clean up industrial processes